This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nevalainen, M. T. Articles by Rui, H. Search for Related Content PubMed PubMed Citation Articles by Nevalainen, M. T. Articles by Rui, H.

Basal Activation of Transcription Factor Signal Transducer and Activator of Transcription (Stat5) in Nonpregnant Mouse and Human Breast Epithelium

United States Military Cancer Institute and Department of Pathology (M.T.N., J.X., H.R.), Uniformed Services University of the Health Sciences, Bethesda, Maryland 20852; Institute of Pathology (L.B.), University of Basel, Basel CH-43003, Switzerland; and Eppley Institute for Research in Cancer and Allied Diseases (K.-U.W.), Nebraska Medical Center, Omaha, Nebraska 68182

Address all correspondence to: Dr. Hallgeir Rui, Georgetown University, Lombardi Cancer, TRB E504, 3970 Reservoir Road Northwest, Washington, DC 20007. E-mail: ruih{at}georgetown.edu.

Transcription factor Stat5 (signal transducer and activator of transcription) is essential for PRL-induced terminal differentiation of mouse mammary epithelial cells during pregnancy and lactation and has been implicated in mammary tumorigenesis. A new and sensitive immunological method to detect active, tyrosine phosphorylated Stat5 in situ revealed that Stat5 is continuously activated in luminal epithelial cells of mouse and human breast, not only during pregnancy and lactation, but also outside of pregnancy. Examination of virgin Stat5a or Stat5b null mice suggested that Stat5a was the primary isoform activated in mammary epithelial cells. Basal activation of Stat5 in mammary epithelium of virgin wild-type mice was continuous throughout estrous cycle and was also detected in 17 of 17 normal human breast tissue specimens analyzed. PRL was identified as the principal factor maintaining basal activation of Stat5 in mammary epithelium of nonpregnant mice based on several lines of evidence. First, administration of PRL, but not GH or epidermal growth factor, uniformly enhanced basal activation of Stat5 in luminal mammary epithelial cells. Second, hypophysectomy disrupted basal activation of Stat5, an effect that was completely reversed by administration of PRL, but only partially by GH. Third, knock-out of the PRL receptor gene markedly reduced basal activation of Stat5, an effect that was maintained in a normalized endocrine environment after transplanting PRL receptor null mammary epithelium into wild-type mice. Continuous activation of Stat5 indicates a role of this transcription factor in normal, nonpregnant breast epithelial cells, and may shed new light on Stat5 involvement in breast tumor promotion.

This article has been cited by other articles:

				S.-H. Tan and M. T Nevalainen Signal transducer and activator of transcription 5A/B in prostate and breast cancers Endocr. Relat. Cancer, June 1, 2008; 15(2): 367 - 390. [Abstract] [Full Text] [PDF]

				S.-H. Tan, A. Dagvadorj, F. Shen, L. Gu, Z. Liao, J. Abdulghani, Y. Zhang, E. P. Gelmann, T. Zellweger, Z. Culig, et al. Transcription Factor Stat5 Synergizes with Androgen Receptor in Prostate Cancer Cells Cancer Res., January 1, 2008; 68(1): 236 - 248. [Abstract] [Full Text] [PDF]

				S. J. Santos, S. Z. Haslam, and S. E. Conrad Estrogen and Progesterone are Critical Regulators of Stat5a Expression in the Mouse Mammary Gland Endocrinology, January 1, 2008; 149(1): 329 - 338. [Abstract] [Full Text] [PDF]

				K. Sakamoto, B. A. Creamer, A. A. Triplett, and K.-U. Wagner The Janus Kinase 2 Is Required for Expression and Nuclear Accumulation of Cyclin D1 in Proliferating Mammary Epithelial Cells Mol. Endocrinol., August 1, 2007; 21(8): 1877 - 1892. [Abstract] [Full Text] [PDF]

				M. J. LeBaron, T. J. Ahonen, M. T. Nevalainen, and H. Rui In Vivo Response-Based Identification of Direct Hormone Target Cell Populations Using High-Density Tissue Arrays Endocrinology, March 1, 2007; 148(3): 989 - 1008. [Abstract] [Full Text] [PDF]

				H Yamashita, M Nishio, Y Ando, Z Zhang, M Hamaguchi, K Mita, S Kobayashi, Y Fujii, and H Iwase Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer. Endocr. Relat. Cancer, September 1, 2006; 13(3): 885 - 893. [Abstract] [Full Text] [PDF]

				Y. Zhao, C. Johansson, T. Tran, R. Bettencourt, Y. Itahana, P.-Y. Desprez, and S. F. Konieczny Identification of a Basic Helix-Loop-Helix Transcription Factor Expressed in Mammary Gland Alveolar Cells and Required for Maintenance of the Differentiated State Mol. Endocrinol., September 1, 2006; 20(9): 2187 - 2198. [Abstract] [Full Text] [PDF]

				J. Nilsson, G. Bjursell, and M. Kannius-Janson Nuclear Jak2 and Transcription Factor NF1-C2: a Novel Mechanism of Prolactin Signaling in Mammary Epithelial Cells Mol. Cell. Biol., August 1, 2006; 26(15): 5663 - 5674. [Abstract] [Full Text] [PDF]

				F E Utama, M J LeBaron, L M Neilson, A S Sultan, A F Parlow, K-U Wagner, and H Rui Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in mice. J. Endocrinol., March 1, 2006; 188(3): 589 - 601. [Abstract] [Full Text] [PDF]

				H. Li, Y. Zhang, A. Glass, T. Zellweger, E. Gehan, L. Bubendorf, E. P. Gelmann, and M. T. Nevalainen Activation of Signal Transducer and Activator of Transcription-5 in Prostate Cancer Predicts Early Recurrence Clin. Cancer Res., August 15, 2005; 11(16): 5863 - 5868. [Abstract] [Full Text] [PDF]

				E. M. Johansson, M. Kannius-Janson, A. Gritli-Linde, G. Bjursell, and J. Nilsson Nuclear Factor 1-C2 Is Regulated by Prolactin and Shows a Distinct Expression Pattern in the Mouse Mammary Epithelial Cells during Development Mol. Endocrinol., April 1, 2005; 19(4): 992 - 1003. [Abstract] [Full Text] [PDF]

				M. T. Tilli, R. Reiter, A. S. Oh, R. T. Henke, K. McDonnell, G. I. Gallicano, P. A. Furth, and A. T. Riegel Overexpression of an N-Terminally Truncated Isoform of the Nuclear Receptor Coactivator Amplified in Breast Cancer 1 Leads to Altered Proliferation of Mammary Epithelial Cells in Transgenic Mice Mol. Endocrinol., March 1, 2005; 19(3): 644 - 656. [Abstract] [Full Text] [PDF]

				C. V. Clevenger Roles and Regulation of Stat Family Transcription Factors in Human Breast Cancer Am. J. Pathol., November 1, 2004; 165(5): 1449 - 1460. [Abstract] [Full Text] [PDF]

				H. Li, T. J. Ahonen, K. Alanen, J. Xie, M. J. LeBaron, T. G. Pretlow, E. L. Ealley, Y. Zhang, M. Nurmi, B. Singh, et al. Activation of Signal Transducer and Activator of Transcription 5 in Human Prostate Cancer Is Associated with High Histological Grade Cancer Res., July 15, 2004; 64(14): 4774 - 4782. [Abstract] [Full Text] [PDF]

				K.-U. Wagner, A. Krempler, A. A. Triplett, Y. Qi, N. M. George, J. Zhu, and H. Rui Impaired Alveologenesis and Maintenance of Secretory Mammary Epithelial Cells in Jak2 Conditional Knockout Mice Mol. Cell. Biol., June 15, 2004; 24(12): 5510 - 5520. [Abstract] [Full Text] [PDF]

				M. T. Nevalainen, J. Xie, J. Torhorst, L. Bubendorf, P. Haas, J. Kononen, G. Sauter, and H. Rui Signal Transducer and Activator of Transcription-5 Activation and Breast Cancer Prognosis J. Clin. Oncol., June 1, 2004; 22(11): 2053 - 2060. [Abstract] [Full Text] [PDF]

				J. W. Mandell Phosphorylation State-Specific Antibodies: Applications in Investigative and Diagnostic Pathology Am. J. Pathol., November 1, 2003; 163(5): 1687 - 1698. [Abstract] [Full Text] [PDF]

				T. J. Ahonen, J. Xie, M. J. LeBaron, J. Zhu, M. Nurmi, K. Alanen, H. Rui, and M. T. Nevalainen Inhibition of Transcription Factor Stat5 Induces Cell Death of Human Prostate Cancer Cells J. Biol. Chem., July 11, 2003; 278(29): 27287 - 27292. [Abstract] [Full Text] [PDF]